In addition, it is worth noting that mutations also occur in the EZH2 gene in approximately 3% of melanomas [141], and furthermore that EZH2 has been shown to cooperate with DNA methylation changes to down-regulate key tumour suppressors and interferon gene signatures [142]. The gene discussed is EZH2; the disease is neoplasm.